Jie Lin

1.5k total citations
55 papers, 1.0k citations indexed

About

Jie Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jie Lin has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 28 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Jie Lin's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (9 papers). Jie Lin is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (9 papers). Jie Lin collaborates with scholars based in China, United States and United Kingdom. Jie Lin's co-authors include Min Yu, Lei Ding, Qinghua Cui, Huan Gu, Wen-Shan Lin, Jiaqi Cao, Kang Guo, Ye Gu, Shuang Wang and Wenting Liao and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Jie Lin

53 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Lin China 21 749 473 185 169 75 55 1.0k
Xin Song China 16 662 0.9× 385 0.8× 211 1.1× 120 0.7× 94 1.3× 31 921
Jar‐Yi Ho Taiwan 19 605 0.8× 333 0.7× 150 0.8× 114 0.7× 90 1.2× 32 892
Liuxing Wang China 18 629 0.8× 402 0.8× 210 1.1× 104 0.6× 85 1.1× 47 905
Dingjun Zhu China 19 582 0.8× 399 0.8× 169 0.9× 162 1.0× 128 1.7× 41 911
Ledong Wan China 13 680 0.9× 438 0.9× 263 1.4× 119 0.7× 147 2.0× 17 1.1k
Jingnan Shen China 17 939 1.3× 663 1.4× 206 1.1× 160 0.9× 76 1.0× 31 1.2k
Rareş Drulă Romania 11 601 0.8× 292 0.6× 189 1.0× 115 0.7× 67 0.9× 18 914
Yi-Chieh Yang Taiwan 15 650 0.9× 325 0.7× 165 0.9× 108 0.6× 68 0.9× 19 869

Countries citing papers authored by Jie Lin

Since Specialization
Citations

This map shows the geographic impact of Jie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Lin more than expected).

Fields of papers citing papers by Jie Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Lin. The network helps show where Jie Lin may publish in the future.

Co-authorship network of co-authors of Jie Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Lin. A scholar is included among the top collaborators of Jie Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Lin. Jie Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Chen, Jiayan, Jingyi Wen, Jie Lin, et al.. (2025). Deoxycholic acid induces reactive oxygen species accumulation and promotes colorectal cancer cell apoptosis through the CaMKII-Ca2+ pathway. World Journal of Gastrointestinal Oncology. 17(8). 107453–107453. 1 indexed citations
5.
Lin, Jie, et al.. (2024). Comprehensive Analyses of PANoptosome with Potential Implications in Cancer Prognosis and Immunotherapy. Biochemical Genetics. 63(1). 331–353. 7 indexed citations
6.
Song, Kai, Yaxuan Wang, Zhiyang Li, et al.. (2024). PSAT1 promotes the progression of colorectal cancer by regulating Hippo-YAP/TAZ-ID1 axis via AMOT. Molecular and Cellular Biochemistry. 480(6). 3647–3668. 7 indexed citations
7.
Su, Dan, Jie Lin, Yang Zhang, et al.. (2024). Characterization of the transmembrane C-type lectin reveals a novel phagocytic receptor for hemocytes of Tegillarca granosa. Aquaculture. 592. 741248–741248. 1 indexed citations
8.
Ren, Xiaoxue, Yubin Xie, Yifan Wu, et al.. (2023). Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. Cell Reports Medicine. 4(11). 101277–101277. 29 indexed citations
9.
10.
Chang, Hong, Rui Cai, Ping Wang, et al.. (2022). Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis. Journal of Translational Medicine. 20(1). 485–485. 7 indexed citations
11.
Ou, Huohui, Qingbo Liu, Jie Lin, et al.. (2021). Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p. Digestive Diseases and Sciences. 66(11). 3903–3915. 5 indexed citations
12.
Cai, Rui, Yuejun Luo, Ziyuan Wang, et al.. (2020). TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer. Carcinogenesis. 41(12). 1755–1766. 12 indexed citations
13.
Hong, Chang, Ping Wang, Xin Zhao, et al.. (2020). LIPG: an inflammation and cancer modulator. Cancer Gene Therapy. 28(1-2). 27–32. 12 indexed citations
14.
Lin, Jie, et al.. (2019). Pipelines for cross-species and genome-wide prediction of long noncoding RNA binding. Nature Protocols. 14(3). 795–818. 20 indexed citations
15.
Zhao, Hui, Tengfei Ma, Jie Lin, et al.. (2018). Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines. Scientific Reports. 8(1). 1949–1949. 32 indexed citations
16.
Feng, Siyang, Di Lu, Jie Lin, et al.. (2018). TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells. Experimental Cell Research. 373(1-2). 44–56. 12 indexed citations
17.
Proia, Theresa A., Feng Jiang, Richard Nicoletti, et al.. (2015). 23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity. Molecular Cancer Therapeutics. 14(8). 1858–1867. 8 indexed citations
18.
Liu, Hao, Bin Wang, Jie Lin, & Liang Zhao. (2014). microRNA-29b: an Emerging Player in Human Cancer. Asian Pacific Journal of Cancer Prevention. 15(21). 9059–9064. 21 indexed citations
19.
Watters, James, Chun Cheng, Pradip K. Majumder, et al.. (2009). De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model. Cancer Research. 69(23). 8949–8957. 31 indexed citations
20.
Huérou, Yvan Le, Indrani W. Gunawardana, Allen A. Thomas, et al.. (2007). Prodrug thiamine analogs as inhibitors of the enzyme transketolase. Bioorganic & Medicinal Chemistry Letters. 18(2). 505–508. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Jar‐Yi Ho Breakdown of academic impact, for papers by Liuxing Wang Breakdown of academic impact, for papers by Dingjun Zhu Breakdown of academic impact, for papers by Ledong Wan Breakdown of academic impact, for papers by Jingnan Shen Breakdown of academic impact, for papers by Rareş Drulă Breakdown of academic impact, for papers by Yi-Chieh Yang
Rankless by CCL
2026